
RegenExtracell
Bone Marrow Concentrate (BMC) is an autologous cell concentrate from bone marrow aspirate.
The bone marrow is known to be rich in a heterogeneous population of mature and pluripotent cells such as the well known blood cell progenitors (hematopoietic stem cells, HSCs), various other immature cells such as mesenchymal stromal cells (MSC’s, which are the musculoskeletal cell precursors), pre-adipocytes, endothelial progenitor cells, etc.
Procedure for autologous cell concentrate preparation from bone marrow aspirate:
- Aspiration of bone marrow from the iliac crest
- Sterile transfer of bone marrow from the collection syringe to the Device
- Centrifugation
- Application of the CELL CONCENTRATE according to the surgical needs
This can then be infused directly in liquid form in the region to be treated or can be seeded in biological scaffolds of various types (membranes, platelet gel, autologous tissue grafts or allografts).
- SKUs
- Brochures
- Clinical Studies
Author
Title
Link
Bone Marrow Concentrate Injection Treatment Improves Short-term Outcomes in Symptomatic Hip Osteoarthritis Patients
Bone Marrow Concentrate in the Treatment of Aneurysmal Bone Cysts: A Case Series Study
Combined Surgical And Medical Treatment For Periprosthetic Femoral Fractures Over A Stable Stem (Vancouver Type B1 And C): A Proposal Of A Therapeutic Algorithm To Reduce The Risk Of Nonunion
Induced membrane technique using enriched bone grafts for treatment of posttraumatic segmental long bone defects
